SIU School of Medicine

Jump directly to a section:

ANCHOR: Aneurysm Treatment Using the HeliFX Aortic Securement System Global Registry

IRB Number

12-189 Identifier


Trial Status

Open for Enrollment
Phase Post Market

Why is this study being done?

Observational study to determine safety and efficacy of the HeliFX Aortic Securement System.

Who is eligible to participate?

Patients undergoing endovascular repair of abdominal aortic aneurysms, or patients undergoing repair of an endoleak or migration after endovascular repair of abdominal aortic aneurysm.

What is involved?

This is an observational study of an FDA-approved device. Data is collected from regular standard care implant and follow-up.

How long is the study?

Patients are followed for five years.

Who can I contact for additional information?

Tiffany Whitaker, RN (217) 545-2531 or

Who is the Principal Investigator of this study?

Kim Hodgson, MD

Where is the trial located?

Springfield, Illinois